Don't you worry… ramping will start soon. The Chair and CEO should both take a walk and vacate their positions for someone with more experience. They’ve done their job of taking this company from single-digit revenue to double-digit, but their time is up. There's some positive spin out there, like the number of deployments and customer referenceability, but revenue and growth are lacking. They seem to have no competitive advantage over other health tech companies like Oracle, Epic, Nervecenter, Intersystems, etc.
I hope they are considering some takeover or merger options to scale up and provide a return on investment.
ALC Price at posting:
7.2¢ Sentiment: Sell Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)